Retention of structure, antigenicity, and biological function of pneumococcal surface protein A (PspA) released from polyanhydride nanoparticles.
about
Polyanhydride Nanoparticle Delivery Platform Dramatically Enhances Killing of Filarial WormsPolyanhydride Nanovaccines Induce Germinal Center B Cell Formation and Sustained Serum Antibody ResponsesSafety and biocompatibility of carbohydrate-functionalized polyanhydride nanoparticles.Respiratory nanoparticle-based vaccines and challenges associated with animal models and translationProduction and purification of an untagged recombinant pneumococcal surface protein A (PspA4Pro) with high-purity and low endotoxin content.The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response.Neuronal protection against oxidative insult by polyanhydride nanoparticle-based mitochondria-targeted antioxidant therapy.Functionalization promotes pathogen-mimicking characteristics of polyanhydride nanoparticle adjuvants.Evaluation of protective efficacy of selected immunodominant B-cell epitopes within virulent surface proteins of S. Pneumoniae.Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection.pH-Responsive Microencapsulation Systems for the Oral Delivery of Polyanhydride Nanoparticles.Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf.Room Temperature Stable PspA-Based Nanovaccine Induces Protective Immunity.
P2860
Q28550462-7361C673-8785-4DFB-9540-ECF1A0907775Q33710195-859A958D-63D6-48B8-94B1-F6F50674AAB4Q34871862-BAC73E20-E07D-4EB2-B392-174CF8F86B77Q36598433-B36A2B82-5F50-4CEF-86AF-BBE2D020BE6BQ38290030-6DC9E289-4958-4AB0-BE4D-25DCDBDEF45BQ38722460-B732CA98-4BBE-4EDA-94AA-489154C3FBD7Q38738244-A269BE71-30B7-418F-A149-FDA2B61D629AQ38757220-9FD66B59-07D8-4FE0-A153-CB0C24264C1FQ47269510-78E3EAF7-5CB0-4044-9B1B-1ECAF9E15FC4Q47649982-84F3786F-01CA-4AFF-AC62-7276005FFB98Q50005095-2C5EC90D-136A-4E9A-976C-7726ADBD6FCFQ50317606-E0BF0919-2DF1-4968-A49B-6B35416744B9Q51732398-9ABF6596-1273-479C-9881-089B0C69C3AE
P2860
Retention of structure, antigenicity, and biological function of pneumococcal surface protein A (PspA) released from polyanhydride nanoparticles.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Retention of structure, antige ...... m polyanhydride nanoparticles.
@en
Retention of structure, antige ...... m polyanhydride nanoparticles.
@nl
type
label
Retention of structure, antige ...... m polyanhydride nanoparticles.
@en
Retention of structure, antige ...... m polyanhydride nanoparticles.
@nl
prefLabel
Retention of structure, antige ...... m polyanhydride nanoparticles.
@en
Retention of structure, antige ...... m polyanhydride nanoparticles.
@nl
P2093
P2860
P1433
P1476
Retention of structure, antige ...... om polyanhydride nanoparticles
@en
P2093
Amy D Schoofs
Balaji Narasimhan
David E Briles
Janice D King
Latrisha K Petersen
Michael J Wannemuehler
Shannon L Haughney
P2860
P304
P356
10.1016/J.ACTBIO.2013.06.006
P577
2013-06-14T00:00:00Z